Abstract
Neuropeptide Y (NPY) occurs in G-protein-coupled receptors and offers targeted effects at the active sites for therapeutic action in various conditions like depression, stress, obesity and cancer. Immune stimulating complexes (ISCOMs) associate peptides with the lipid systems for enhancing antigen targeting to provide site-specific action and B-cell response. The present study focused on the encapsulation of NPY in ISCOMs to comprise dual action in the form of immunity modulation and management of breast cancer by arresting G0/G1 phase. The colloidal ISCOMs were prepared by coupling method and further optimized by Box-Behnken design of Design of Experiment (DoE) software. The NPY-loaded ISCOMs (formulation ISCN) were characterized by various parameters with higher % encapsulation efficiency of 87.99 ± 1.87% and in-vitro release of 84.16±3.2% of NPY for 24 h. The study of MTT assay on MCF-7 cell line for formulation ISCN exhibited a significant decrease in the cell growth of 66.41±4.7% at 10 µg/mL compared to plain NPY (52.21±0.04%). The MCF-7 cells showed a significant reduction in cytokine levels in the presence of formulation ISCN wherein TH1(TNF-α) and TH2(IL-10) levels were found to be 25.12±3.11 pg/mL and 35.76±4.23 pg/mL, respectively. The cell cycle study demonstrated that significant cells were blocked in the G0/G1 phase with 57.8±3.02% of cell apoptosis using formulation ISCN. The formulation ISCN was found to prolong t1/2 and increase AUC than plain NPY via intravenous administration due to complex formation with phospholipid. Hence, ISCOMs-based NPY system will be a promising approach for dual action as immunomodulation and anticancer effects by controlling the release of NPY.
Similar content being viewed by others
References
O. Abdifetah, K. Na-Bangchang, Int. J. Nanomedicine 14, 5659 (2019)
R. Batchelor, C.J. Windle, S. Buchoux, M. Lorch, J. Biol. Chem. 285, 41402 (2010)
I.A. Bontempi, M.H. Vicco, G. Cabrera, S.R. Villar, F.B. González, E.A. Roggero, P. Ameloot, N. Callewaert, A.R. Pérez, I.S. Marcipar, Vaccine 33, 1274 (2015)
F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, CA. Cancer J. Clin. 68, 394 (2018)
M.L. Briuglia, C. Rotella, A. McFarlane, D.A. Lamprou, Drug Deliv. Transl. Res. 5, 231 (2015)
J. Cauzzo, N. Jayakumar, B.S. Ahluwalia, A. Ahmad, and N. Škalko-Basnet, Pharmaceutics 13, (2021)
K.K. Chiruvella, K. Panjamurthy, B. Choudhary, O. Joy, S.C. Raghavan, Int. J. Biomed. Sci. 6, 182 (2010)
B. Corthésy, G. Bioley, Front. Immunol. 9, (2018)
M. Danaei, M. Dehghankhold, S. Ataei, F. Hasanzadeh Davarani, R. Javanmard, A. Dokhani, S. Khorasani, M.R. Mozafari, Pharmaceutics 10, 1 (2018)
D. Desai, P. Shende, Curr. Protein Pept. Sci. 21, 1 (2020a)
D. Desai, P. Shende, J. Pharm. Innov. (2020b)
D. Desai, P. Shende, J. Drug Deliv Sci. Technol. 65, 102692 (2021a)
D. Desai, P. Shende, Biotechnol. J. 16, 1 (2021b)
V. Doye, E. Hurt, Curr. Opin. Cell. Biol. 9, 401 (1997)
P. Duewell, U. Kisser, K. Heckelsmiller, S. Hoves, P. Stoitzner, S. Koernig, A.B. Morelli, B.E. Clausen, M. Dauer, A. Eigler, D. Anz, C. Bourquin, E. Maraskovsky, S. Endres, M. Schnurr, J. Immunol. 187, 55 (2011)
M. Dyck, A. Kerth, A. Blume, M. Lösche, J. Phys. Chem. B 110, 22152 (2006)
D. Eshun, R. Saraf, S. Bae, J. Jeganathan, F. Mahmood, S. Dilmen, Q. Ke, D. Lee, P.M. Kang, R. Matyal, J. Appl. Physiol. 122, 1388 (2017)
X.J. Fang, H. Jiang, Y.Q. Zhu, L.Y. Zhang, Q.H. Fan, Y. Tian, Oncol. Rep. 31, 2735 (2014)
A. Farzi, F. Reichmann, P. Holzer, Acta Physiol. 213, 603 (2015)
G.J.P. Fernando, D.J. Stenzel, R.W. Tindle, M.S. Merza, B. Morein, I.H. Frazer, Vaccine 13, 1460 (1995)
C. Fossum, B. Hjertner, V. Ahlberg, W. Charerntantanakul, K. McIntosh, L. Fuxler, N. Balagunaseelan, P. Wallgren, and K. Lövgren Bengtsson, Vet. Immunol. Immunopathol. 158, 53 (2014)
S. Galdiero, A. Falanga, M. Cantisani, M. Vitiello, G. Morelli, M. Galdiero, Int. J. Mol. Sci. 14, 18758 (2013)
R. Gaspar, F. Coelho, B.F.B. Silva, Molecules 25, 5006 (2020)
S. Goudarzi, S.E. Gilchrist, S. Hafizi, Cells 9, (2020)
C. de Groot, M. Müsken, M. Bleckmann, T. Ebensen, C.A. Guzmán, and C. C. Müller-Goymann, Vaccine 37, 4975 (2019)
N. Harbeck, F. Penault-Llorca, J. Cortes, M. Gnant, N. Houssami, P. Poortmans, K. Ruddy, J. Tsang, F. Cardoso, Nat. Rev. Dis. Prim. 5, (2019)
C. Hearnden, E.C. Lavelle, Adjuvant Strategies for Vaccines: The Use of Adjuvants within the Cancer Vaccine Setting (Second Edi (Elsevier, 2013)
M. Heilig, Neuropeptides 38, 213 (2004)
T. Jason, K. Joanna, Physiol. Behav. 176, 139 (2017)
G.F.A. Kersten, A. Spiekstra, E.C. Beuvery, D.J.A. Crommelin, Biochim. Biophys. Acta 1062, 165 (1991)
I.U. Khan, D. Zwanziger, I. Böhme, M. Javed, H. Naseer, S.W. Hyder, A.G. Beck-Sickinger, Angew. Chemie - Int. Ed. 49, 1155 (2010)
K.M. Kim, B.M. Choi, S.W. Park, S.H. Lee, L.V. Christensen, J. Zhou, B.H. Yoo, H.W. Shin, K.S. Bae, S.E. Kern, S.H. Kang, G.J. Noh, Anesthesiology 106, 924 (2007)
R. Klippstein, D. Pozo, Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery, 1st edn. (Elsevier Inc., 2015)
A. Kuzmis, S.B. Lim, E. Desai, E. Jeon, B.S. Lee, I. Rubinstein, H. Önyüksel, Nanomed. Nanatechnol. Biol Med 7, 464 (2011)
W.S. Lau, W.F. Chen, R.Y.K. Chan, D.A. Guo, M.S. Wong, Br. J. Pharmacol. 156, 1136 (2009)
J. Li, Y. Tian, A. Wu, Regen Biomater. 2, 215 (2015)
S.T. Lin, Y.Z. Li, X.Q. Sun, Q.Q. Chen, S.F. Huang, S. Lin, S.Q. Cai, Front. Endocrinol. (Lausanne) 12, 1 (2021)
Z. Liu, J. Fu, S. Xiao, D. Wang, RSC Adv. 9, 29847 (2019)
K. Lövgren-Bengtsson, B. Morein, Vaccine Adjuv. 42, 239 (2003)
M. Mahato, R. Sarkar, P. Pal, G.B. Talapatra, Indian J. Phys. 89, 997 (2015)
F.C. Mansilla, O.L. Franco-Mahecha, M. ángeles Lavoria, D.P. Moore, A.N. Giraldez, M.E. Iglesias, M. Wilda, A.V. Capozzo, Vaccine 30, 1124 (2012)
P.J. Medeiros, B.K. Al-Khazraji, N.M. Novielli, L.M. Postovit, A.F. Chambers, D.N. Jackson, Int. J. Cancer 131, 276 (2012)
P. Midoux, G. Breuzard, J. Gomez, C. Pichon, Curr. Gene Ther. 8, 335 (2008)
B. Morein, Vet. Microbiol. 23, 79 (1990)
A.M. Mowat, G. Reid, Curr. Protoc. Immunol. 16, 1 (1995)
F. Odeh, S.I. Ismail, R. Abu-Dahab, I.S. Mahmoud, and A. Al Bawab, Drug Deliv. 19, 371 (2012)
C. Park, J. Kim, S.B. Ko, Y.K. Choi, H. Jeong, H. Woo, H. Kang, I. Bang, S.A. Kim, T.Y. Yoon, C. Seok, W. Im, H.J. Choi, Nat. Commun. 13, (2022)
T. Pedrazzini, F. Pralong, E. Grouzmann, Cell. Mol. Life Sci. 60, 350 (2003)
E.K. Potter, Neurosci. Lett. 77, 243 (1987)
M. Ramvikas, M. Arumugam, S.R. Chakrabarti, K.S. Jaganathan, in Micro- Nanotechnol. Vaccine Dev. (2017), pp. 279–301
F. Reichmann, P. Holzer, Neuropeptides 55, 99 (2016)
C. Rydyznski Moderbacher, S.I. Ramirez, J.M. Dan, A. Grifoni, K.M. Hastie, D. Weiskopf, S. Belanger, R.K. Abbott, C. Kim, J. Choi, Y. Kato, E.G. Crotty, C. Kim, S.A. Rawlings, J. Mateus, L.P.V. Tse, A. Frazier, R. Baric, B. Peters, J. Greenbaum, E. Ollmann Saphire, D.M. Smith, A. Sette, S. Crotty, Cell 183, 996 (2020)
A. Santos-Carvalho, A.F. Ambrósio, C. Cavadas, Prog. Retin. Eye Res. 47, 19 (2015)
P. Shende, D. Desai, Adv. Exp. Med. Biol. 1237, 37 (2020)
P. Shende, N. Ture, R.S. Gaud, F. Trotta, Int. J. Pharm. 558, 250 (2019)
A. Sjölander, J.C. Cox, I.G. Barr, J. Leukoc. Biol. 64, 713 (1998)
H.X. Sun, Y. Xie, Y.P. Ye, Vaccine 27, 4388 (2009)
D.R. Telange, N.K. Sohail, A.T. Hemke, P.S. Kharkar, A.M. Pethe, Drug Deliv. Transl. Res. 11, 1056 (2021)
L. Thomas, H.A. Scheidt, A. Bettio, A.G. Beck-Sickinger, D. Huster, O. Zschörnig, Eur. Biophys. J. 38, 663 (2009)
L. Troncone, E. De Lisa, C. Bertapelle, A. Porcellini, P. Laccetti, G. Polese, A. Di Cosmo, J. Nat. Hist. 49, 1457 (2015)
N. Ture, S. Govardhane, P. Shende, Colloids Surf. Physicochem Eng Asp 609, 125671 (2021)
K. Vermaelen, Front. Immunol. 10, 1 (2019)
A.G. Waks, E.P. Winer, JAMA - J. Am. Med. Assoc. 321, 288 (2019)
H. Wu, M. Yu, Y. Miao, S. He, Z. Dai, W. Song, Y. Liu, S. Song, E. Ahmad, D. Wang, Y. Gan, Acta Pharm. Sin B 9, 858 (2019)
D. Yokota, M. Moraes, S.C. Pinho, Brazilian J. Chem. Eng. 29, 325 (2012)
G.K. Zorzi, R.S. Schuh, V.J. Maschio, N.T. Brazil, M.B. Rott, H.F. Teixeira, Colloids Surf. B Biointerfaces 173, 725 (2019)
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Desai, D., Shende, P. Dual-action of colloidal ISCOMs: an optimized approach using Box-Behnken design for the management of breast cancer. Biomed Microdevices 24, 28 (2022). https://doi.org/10.1007/s10544-022-00625-z
Accepted:
Published:
DOI: https://doi.org/10.1007/s10544-022-00625-z